We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Exokinetics Stock

Invest in or calculate the value of your shares in Exokinetics or other pre-IPO companies through EquityZen's platform.

Get Started

Exokinetics Stock (EXOK)

Exokinetics invents Zeen, a new mobility device that helps those with mobility limitations.

About Exokinetics Stock

Founded

2017

Headquarters

West Chester, PA, US

Industries

Health Care

Exokinetics invents Zeen, a new mobility device that helps those with mobility limitations. People with mobility limitations can continue going on adventures and doing the things they love through Zeen. The Zeen is designed with guidance from physical therapists for superior stability. With full – or partial – weight support on the riding saddle, their own legs propel them while the Zeen stabilizes them and carries their weight. Zeen can lift and lower them from standing to a seated position and back again instantly. And because their weight is supported from beneath, their hands are free to carry their own plate, drink or dog leash without any assistance. Coming soon: Zeen Trunk Lift Straps. Trunk lift straps reduce lift and lower weight by half and slide in and out of trunks easily with no pinched fingers.

Exokinetics Press Mentions

Stay in the know about the latest news on Exokinetics

Lifting mechanism and chanirs

patents • Apr 15, 2024

Elevating walker chair and components

patents • Apr 15, 2024

Exokinetics Raises Series B Funding Round

finsmes • Nov 02, 2022

Locked Features

Join now and verify your accreditation status to gain access to:

  • Exokinetics current valuation
  • Exokinetics stock price
  • Available deals in Exokinetics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Exokinetics stock?

Accredited investors can buy pre-IPO stock in companies like Exokinetics through EquityZen funds. These investments are made available by existing Exokinetics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Exokinetics stock?

Shareholders can sell their Exokinetics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."